Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 04 tags : Positive save search
MuleSoft Positioned as a Leader Again in the Gartner® Magic Quadrant™ for Enterprise Integration Platform as a Service and the Magic Quadrant for Full Life Cycle API Management
Published: 2021-10-04 (Crawled : 17:00) - prnewswire.com
CRM S | $270.37 -0.57% -0.06% 4.9M
|
Technology Services
|
| O: -0.01%
H: 0.03%
C: -1.58%
IT | $440.38 -2.05% 0.0% 450K
|
Commercial Services
|
| O: -0.43%
H: 1.58%
C: 0.08%
integration positive
Pfizer and BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine Booster in the European Union
Published: 2021-10-04 (Crawled : 17:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.54%
H: 0.77%
C: 0.17%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -7.79%
H: 7.42%
C: 5.95%
covid europe positive vaccine chmp covid-19
Acurx Presents Positive Ibezapolstat Microbiome Data from Its Phase 2a Trial at IDWeek
Published: 2021-10-04 (Crawled : 14:00) - biospace.com/
ACXP | $2.02 -5.16% -5.45% 94K
|
Professional, Scientific, and T...
|
| O: -9.31%
H: 9.42%
C: -1.38%
phase 2 positive trial phase 2b
Turning Point Therapeutics Granted Breakthrough Therapy Designation for Repotrectinib Treatment in Patients with NTRK-Positive, TKI-Pretreated Advanced Solid Tumors
Published: 2021-10-04 (Crawled : 13:15) - globenewswire.com
TPTX | $76.01 -0.03%
|
Health Technology
|
| O: -0.53%
H: 2.39%
C: -0.01%
treatment solid tumors positive therapy breakthrough therapy granted grant designation
Zai Lab Partner Turning Point Therapeutics Granted Breakthrough Therapy Designation for Repotrectinib Treatment in Patients With NTRK-Positive, TKI-Pretreated Advanced Solid Tumors
Published: 2021-10-04 (Crawled : 13:15) - globenewswire.com
ZLAB | $14.08 -0.99% -0.99% 470K
|
Health Technology
|
| O: -4.58%
H: 2.65%
C: 0.49%
TPTX | $76.01 -0.03%
|
Health Technology
|
| O: -0.53%
H: 2.39%
C: -0.01%
treatment solid tumors positive therapy breakthrough therapy granted designation
PDS Biotech Enrolls First Stage of Checkpoint Inhibitor Naïve Patient Arm of Phase 2 Clinical Trial in Advanced HPV-16 Positive Head and Neck Cancer
Published: 2021-10-04 (Crawled : 13:00) - globenewswire.com
PDSB | $2.64 -8.97% -9.85% 880K
|
Health Technology
|
| O: -4.78%
H: 2.41%
C: 0.0%
phase 2 positive hpv cancer biotech iot trial enroll
OpGen Provides Business Update and Announces Preliminary Unaudited Revenue and Cash Position for Third Quarter 2021
Published: 2021-10-04 (Crawled : 12:00) - globenewswire.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: 24.37%
H: 2.31%
C: -15.27%
positive
Berry Corporation (bry) Positioned to Be a Leader in California’s Well Abandonment and Fugitive Emission Reduction Efforts
Published: 2021-10-04 (Crawled : 11:00) - globenewswire.com
BRY | $8.415 1.51% 1.49% 600K
|
Energy Minerals
|
| O: 5.19%
H: 5.6%
C: -0.4%
positive
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.